The single nucleotide polymorphism A118G alters functional properties of the human mu opioid receptor

Single-nucleotide polymorphism in the human mu opioid receptor gene alters β-endorphin binding and activity: Possible implications for opiate addiction

Bond, C. E., LaForge, K. S., Tian, M., Melia, D., Zhang, S., Borg, L., Gong, J., Schluger, J. H., Strong, J. A., Leal, S. M., et al. (1998) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.95.16.9608 · Cited by 1,072 · see citing works

Genetic influences on impulsivity, risk taking, stress responsivity and vulnerability to drug abuse and addiction

Kreek, M. J., Nielsen, D. A., Butelman, E. R., & LaForge, K. S. (2005) · Nature Neuroscience · doi:10.1038/nn1583 · Cited by 1,024 · see citing works

A Functional Polymorphism of the μ-Opioid Receptor Gene is Associated with Naltrexone Response in Alcohol-Dependent Patients

Oslin, D. W., Berrettini, W., Kranzler, H. R., Pettinati, H., Gelernter, J., Volpicelli, J. R., & O'Brien, C. P. (2003) · Neuropsychopharmacology · doi:10.1038/sj.npp.1300219 · Cited by 571 · see citing works

Allelic Expression Imbalance of Human mu Opioid Receptor (OPRM1) Caused by Variant A118G

Zhang, Y., Wang, D., Johnson, A. D., Papp, A. C., & Sadée, W. (2005) · Journal of Biological Chemistry · doi:10.1074/jbc.m504942200 · Cited by 563 · see citing works

Stress-Induced Cocaine Craving and Hypothalamic-Pituitary-Adrenal Responses Are Predictive of Cocaine Relapse Outcomes

Sinha, R., Garcia, M., Paliwal, P., Kreek, M. J., & Rounsaville, B. J. (2006) · Archives of General Psychiatry · doi:10.1001/archpsyc.63.3.324 · Cited by 528 · see citing works

Pharmacogenetics and Human Molecular Genetics of Opiate and Cocaine Addictions and Their Treatments

Kreek, M. J., Bart, G., Lilly, C., Laforge, K. S., & Nielsen, D. A. (2005) · Pharmacological Reviews · doi:10.1124/pr.57.1.1 · Cited by 391 · see citing works

Pharmacotherapy of addictions

Kreek, M. J., LaForge, K. S., & Butelman, E. R. (2002) · Nature Reviews Drug Discovery · doi:10.1038/nrd897 · Cited by 371 · see citing works

Sequence variability and candidate gene analysis in complex disease: association of micro opioid receptor gene variation with substance dependence

Hoehe, M. R. (2000) · Human Molecular Genetics · doi:10.1093/hmg/9.19.2895 · Cited by 288 · see citing works

μ opioid receptor gene variants: lack of association with alcohol dependence

Bergen, A. W., Kokoszka, J., Peterson, R. J., Long, J. C., Virkkunen, M. E., Linnoila, M., & Goldman, D. A. (1997) · Molecular Psychiatry · doi:10.1038/sj.mp.4000331 · Cited by 271 · see citing works

Effect of the A118G polymorphism on binding affinity, potency and agonist‐mediated endocytosis, desensitization, and resensitization of the human mu‐opioid receptor

Beyer, A., Koch, T., Schröder, H., Schulz, S., & Höllt, V. (2004) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.2004.02340.x · Cited by 258 · see citing works

The Mu-Opioid Receptor Gene Polymorphism (A118G) Alters HPA Axis Activation Induced by Opioid Receptor Blockade

Wand, G. S. (2002) · Neuropsychopharmacology · doi:10.1016/s0893-133x(01)00294-9 · Cited by 246 · see citing works

A Single Nucleotide Polymorphic Mutation in the Human μ-Opioid Receptor Severely Impairs Receptor Signaling

Befort, K., Filliol, D., Décaillot, F. M., Gavériaux‐Ruff, C., Hoehe, M. R., & Kieffer, B. L. (2001) · Journal of Biological Chemistry · doi:10.1074/jbc.m006352200 · Cited by 241 · see citing works

Genetics of two μ opioid receptor gene (OPRM1) exon I polymorphisms: population studies, and allele frequencies in alcohol- and drug-dependent subjects

Gelernter, J. E., Kranzler, H. R., & Cubells, J. F. (1999) · Molecular Psychiatry · doi:10.1038/sj.mp.4000556 · Cited by 241 · see citing works

Increased Attributable Risk Related to a Functional μ-Opioid Receptor Gene Polymorphism in Association with Alcohol Dependence in Central Sweden

Bart, G. B., Kreek, M. J., Ott, J., LaForge, K. S., Proudnikov, D., Pollak, L., & Heilig, M. A. (2004) · Neuropsychopharmacology · doi:10.1038/sj.npp.1300598 · Cited by 220 · see citing works

Amino Acid 49 Polymorphisms of the Human β 1 -Adrenergic Receptor Affect Agonist-Promoted Trafficking

Rathz, D. A., Brown, K. M., Kramer, L. A., & Liggett, S. B. (2002) · Journal of Cardiovascular Pharmacology · doi:10.1097/00005344-200202000-00001 · Cited by 208 · see citing works

Substantial attributable risk related to a functional mu-opioid receptor gene polymorphism in association with heroin addiction in central Sweden

Bart, G. B., Heilig, M. A., LaForge, K. S., Pollak, L., Leal, S. M., Ott, J., & Kreek, M. J. (2004) · Molecular Psychiatry · doi:10.1038/sj.mp.4001504 · Cited by 177 · see citing works

Identification of the Sites of N-Linked Glycosylation on the Human Calcium Receptor and Assessment of Their Role in Cell Surface Expression and Signal Transduction

Ray, K., Clapp, P., Goldsmith, P. K., & Spiegel, A. M. (1998) · Journal of Biological Chemistry · doi:10.1074/jbc.273.51.34558 · Cited by 156 · see citing works

Opioid receptor and peptide gene polymorphisms: potential implications for addictions

LaForge, K. S., Yuferov, V. P., & Kreek, M. J. (2000) · European Journal of Pharmacology · doi:10.1016/s0014-2999(00)00819-0 · Cited by 152 · see citing works

Association between mu opioid receptor gene polymorphisms and Chinese heroin addicts

Szeto, C. Y.-K., Tang, N. L. S., Lee, D. T. S., & Stadlin, A. (2001) · Neuroreport · doi:10.1097/00001756-200105080-00011 · Cited by 145 · see citing works

Association between the cortisol response to opioid blockade and the Asn40Asp polymorphism at the μ‐opioid receptor locus (OPRM1)

Hernández–Ávila, C. A., Wand, G. S., Luο, X., Gelernter, J. E., & Kranzler, H. R. (2003) · American Journal of Medical Genetics Part B Neuropsychiatric Genetics · doi:10.1002/ajmg.b.10054 · Cited by 144 · see citing works

Nalmefene Induced Elevation in Serum Prolactin in Normal Human Volunteers: Partial Kappa Opioid Agonist Activity?

Bart, G. B., Schluger, J. H., Borg, L., Ho, A., Bidlack, J. M., & Kreek, M. J. (2005) · Neuropsychopharmacology · doi:10.1038/sj.npp.1300811 · Cited by 143 · see citing works

The Mu-Opioid Receptor Polymorphism A118G Predicts Cortisol Responses to Naloxone and Stress

Chong, R. Y., Oswald, L. M., Yang, X., Uhart, M., Lin, P., & Wand, G. S. (2005) · Neuropsychopharmacology · doi:10.1038/sj.npp.1300856 · Cited by 138 · see citing works

Adenylyl cyclase type 5 (AC5) is an essential mediator of morphine action

Kim, K.-S., Lee, K.-W., Lee, K.-W., Im, J.-Y., Yoo, J. Y., Kim, S.-W., Lee, J.-K., Nestler, E. J., & Han, P.-L. (2006) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0508812103 · Cited by 123 · see citing works

Nonreplication of association between mu-opioid-receptor gene (OPRM1) A118G polymorphism and substance dependence.

Franke, P. E., Wang, T., Nöthen, M. M., Knapp, M., Neidt, H., Albrecht, S., Jahnes, E., Propping, P., & Maier, W. (2001) · PubMed · Cited by 119 · see citing works

The Carboxyl Terminus of the Human Calcium Receptor

Ray, K., Fan, G.-F., Goldsmith, P. K., & Spiegel, A. M. (1997) · Journal of Biological Chemistry · doi:10.1074/jbc.272.50.31355 · Cited by 118 · see citing works

Haplotypes at the OPRM1 locus are associated with susceptibility to substance dependence in European‐Americans

Luο, X., Kranzler, H. R., Zhao, H., & Gelernter, J. E. (2003) · American Journal of Medical Genetics Part B Neuropsychiatric Genetics · doi:10.1002/ajmg.b.20034 · Cited by 107 · see citing works

Oligomerization of opioid receptors

Gomes, I., Filipovska, J., Jordan, B. A., & Devi, L. A. (2002) · Methods · doi:10.1016/s1046-2023(02)00094-4 · Cited by 96 · see citing works

Nalmefene Causes Greater Hypothalamic‐Pituitary‐Adrenal Axis Activation than Naloxone in Normal Volunteers: Implications for the Treatment of Alcoholism

Schluger, J. H., Ho, A., Borg, L., Porter, M., Maniar, S., Gunduz, M., Perret, G., King, A. C., & Kreek, M. J. (1998) · Alcoholism Clinical and Experimental Research · doi:10.1111/j.1530-0277.1998.tb03931.x · Cited by 93 · see citing works

N-Linked Glycosylation of the Human Ca2+ Receptor Is Essential for Its Expression at the Cell Surface

Fan, G., Goldsmith, P. K., Collins, R. M., Dunn, C., Krapcho, K. J., ROGERS, K. V., & Spiegel, A. M. (1997) · Endocrinology · doi:10.1210/endo.138.5.5131 · Cited by 88 · see citing works

Human mu opioid receptor gene polymorphisms and vulnerability to substance abuse

Berrettini, W. H., Hoehe, M. R., Ferraro, T. N., DeMaria, P. A., & Gottheil, E. (1997) · Addiction Biology · doi:10.1080/13556219772598 · Cited by 77 · see citing works

Association of Functional Opioid Receptor Genotypes With Alcohol Dependence in Koreans

Kim, S., Kim, C., Kang, D., Kim, Y., Byun, W., Kim, S., Park, J., Kim, M.-J., & Oslin, D. W. (2004) · Alcoholism Clinical and Experimental Research · doi:10.1097/01.alc.0000130803.62768.ab · Cited by 74 · see citing works

Allelic Variation S268P of the Human μ-Opioid Receptor Affects Both Desensitization and G Protein Coupling

Koch, T., Kroslak, T., Averbeck, M., Mayer, P. E., Schröder, H., Raulf, E., & Höllt, V. (2000) · Molecular Pharmacology · doi:10.1124/mol.58.2.328 · Cited by 73 · see citing works

N-linked Glycosylation Is Required for Plasma Membrane Localization of D5, but Not D1, Dopamine Receptors in Transfected Mammalian Cells

Karpa, K. D., Lidow, M. S., Pickering, M., Levenson, R. G., & Bergson, C. M. (1999) · Molecular Pharmacology · doi:10.1124/mol.56.5.1071 · Cited by 61 · see citing works

The Role of N-Glycosylation for Functional Expression of the Human Platelet-activating Factor Receptor

Rodríguez, C. G., Cundell, D. R., TUOMANEN, E. I., Kolakowski, L. F., Gerard, C. J., & Gerard, N. P. (1995) · Journal of Biological Chemistry · doi:10.1074/jbc.270.42.25178 · Cited by 60 · see citing works

Glycosylation of the Human Prostacyclin Receptor: Role in Ligand Binding and Signal Transduction

Zhang, Z., Austin, S. C., & Smyth, E. M. (2001) · Molecular Pharmacology · doi:10.1016/s0026-895x(24)12609-0 · Cited by 57 · see citing works

Modulation of Ca2+ Channels by Heterologously Expressed Wild-Type and Mutant Human μ-Opioid Receptors (hMORs) Containing the A118G Single-Nucleotide Polymorphism

Margas, W., Zubkoff, I., Schuler, H. G., Janicki, P. K., & Ruiz-Velasco, V. (2006) · Journal of Neurophysiology · doi:10.1152/jn.01007.2006 · Cited by 52 · see citing works

μ Opioid receptor: role for the amino terminus as a determinant of ligand binding affinity

Chaturvedi, K., Shahrestanifar, M., & Howells, R. (2000) · Molecular Brain Research · doi:10.1016/s0169-328x(99)00332-0 · Cited by 51 · see citing works

Requirement of N-glycosylation of the prostaglandin E2 receptor EP3β for correct sorting to the plasma membrane but not for correct folding

Böer, U., Neuschäfer‐Rube, F., Möller, U., & Püschel, G. P. (2000) · Biochemical Journal · doi:10.1042/bj3500839 · Cited by 43 · see citing works

Functional role of N‐linked glycosylation on the rat melanin‐concentrating hormone receptor 1

Saito, Y., Tetsuka, M., Li, Y., Kawamura, Y., & Maruyama, K. (2002) · FEBS Letters · doi:10.1016/s0014-5793(02)03744-4 · Cited by 35 · see citing works

Glycosylation of the calcitonin receptor‐like receptor at Asn60 or Asn112 is important for cell surface expression

Bühlmann, N., Aldecoa, A., Leuthäuser, K., Gujer, R., Muff, R., Fischer, J. A., & Born, W. (2000) · FEBS Letters · doi:10.1016/s0014-5793(00)02259-6 · Cited by 26 · see citing works

Mu opioid receptor gene polymorphism and neuroleptic-induced tardive dyskinesia in patients with schizophrenia

Tan, E., Chong, S., Mahendran, R., Tan, C. H., & Teo, Y. (2003) · Schizophrenia Research · doi:10.1016/s0920-9964(02)00491-7 · Cited by 17 · see citing works

The broad autism phenotype: A complementary strategy for molecular genetic studies of autism

(2001) · doi:10.1002/1096-8628(20010108)105:1

Regulation of μ-opioid receptors: desensitization, phosphorylation, internalization, and tolerance

Williams, J. T., Ingram, S. L., Henderson, G., Chavkin, C., von Zastrow, M., Schulz, S., Koch, T., Evans, C. J., & Christie, M. J. (2013) · Pharmacological Reviews · doi:10.1124/pr.112.005942 · Cited by 802 · see citing works

Mu Opioids and Their Receptors: Evolution of a Concept

Pasternak, G. W., & Pan, Y. (2013) · Pharmacological Reviews · doi:10.1124/pr.112.007138 · Cited by 582 · see citing works

Opioid receptors: drivers to addiction?

Darcq, E., & Kieffer, B. L. (2018) · Nature reviews. Neuroscience · doi:10.1038/s41583-018-0028-x · Cited by 354 · see citing works

Dopamine for “Wanting” and Opioids for “Liking”: A Comparison of Obese Adults With and Without Binge Eating

Davis, C. A., Levitan, R. D., Reid, C., Carter, J. C., Kaplan, A. S., Patte, K. A., King, N., Curtis, C., & Kennedy, J. L. (2009) · Obesity · doi:10.1038/oby.2009.52 · Cited by 314 · see citing works

The behavioral, anatomical and pharmacological parallels between social attachment, love and addiction

Burkett, J. P., & Young, L. J. (2012) · Psychopharmacology · doi:10.1007/s00213-012-2794-x · Cited by 307 · see citing works

The Interpersonal Dimension of Borderline Personality Disorder: Toward a Neuropeptide Model

Stanley, B., & Siever, L. J. (2009) · American Journal of Psychiatry · doi:10.1176/appi.ajp.2009.09050744 · Cited by 291 · see citing works

Variation in the μ-opioid receptor gene ( <i>OPRM1</i> ) is associated with dispositional and neural sensitivity to social rejection

Way, B. M., Taylor, S. E., & Eisenberger, N. I. (2009) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0812612106 · Cited by 264 · see citing works

Genetics and the placebo effect: the placebome

Hall, K. T., Loscalzo, J., & Kaptchuk, T. J. (2015) · Trends in Molecular Medicine · doi:10.1016/j.molmed.2015.02.009 · Cited by 271 · see citing works

Pharmacogenetic approaches to the treatment of alcohol addiction

Heilig, M. A., Goldman, D. A., Berrettini, W. H., & O’Brien, C. P. (2011) · Nature reviews. Neuroscience · doi:10.1038/nrn3110 · Cited by 249 · see citing works

Opiate addiction and cocaine addiction: underlying molecular neurobiology and genetics

Kreek, M. J., Levran, O., Reed, B., Schlussman, S. D., Zhou, Y., & Butelman, E. R. (2012) · Journal of Clinical Investigation · doi:10.1172/jci60390 · Cited by 220 · see citing works

Meta-analysis of the relevance of the OPRM1 118A>G genetic variant for pain treatment

Walter, C., & Lötsch, J. (2009) · Pain · doi:10.1016/j.pain.2009.07.013 · Cited by 200 · see citing works

The genetics of addiction—a translational perspective

Arpana Agrawal, A., Verweij, K. J. H., Gillespie, N. A., Heath, A. C., Lessov‐Schlaggar, C. N., Martin, N. G., Nelson, E. C., Slutske, W. S., Whitfield, J. B., & Lynskey, M. T. (2012) · Translational Psychiatry · doi:10.1038/tp.2012.54 · Cited by 198 · see citing works

Variation at the mu-opioid receptor gene ( <i>OPRM1</i> ) influences attachment behavior in infant primates

Barr, C. S., Schwandt, M. L., Lindell, S. G., Higley, J. D., Maestripieri, D., Goldman, D., Suomi, S. J., & Heilig, M. (2008) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0710225105 · Cited by 191 · see citing works

Endogenous opioid system dysregulation in depression: implications for new therapeutic approaches

Peciña, M., Karp, J. F., Mathew, S. J., Todtenkopf, M. S., Ehrich, E. W., & Zubieta, J.-K. (2018) · Molecular Psychiatry · doi:10.1038/s41380-018-0117-2 · Cited by 188 · see citing works

Effects of the Mu Opioid Receptor Polymorphism (OPRM1 A118G) on Pain Regulation, Placebo Effects and Associated Personality Trait Measures

Peciña, M., Love, T., Stohler, C. S., Goldman, D. A., & Zubieta, J.-K. (2014) · Neuropsychopharmacology · doi:10.1038/npp.2014.272 · Cited by 161 · see citing works

Mouse model of OPRM1 (A118G) polymorphism has sex-specific effects on drug-mediated behavior

Mague, S. D., Isiegas, C., Huang, P., Liu‐Chen, L., Lerman, C. E., & Blendy, J. A. (2009) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0901800106 · Cited by 160 · see citing works

OPRM1 A118G Gene Variant and Postoperative Opioid Requirement

Hwang, I. C., Park, J. Y., Myung, S., Ahn, H. Y., Fukuda, K., & Liao, Q. (2014) · Anesthesiology · doi:10.1097/aln.0000000000000405 · Cited by 151 · see citing works

A Common Human μ-Opioid Receptor Genetic Variant Diminishes the Receptor Signaling Efficacy in Brain Regions Processing the Sensory Information of Pain

Oertel, B. G., Kettner, M., Scholich, K., Renné, C., Roskam, B., Geißlinger, G., Schmidt, P. H., & Lötsch, J. (2008) · Journal of Biological Chemistry · doi:10.1074/jbc.m807030200 · Cited by 148 · see citing works

Genetic variability of the μ-opioid receptor influences intrathecal fentanyl analgesia requirements in laboring women ☆

Landau, R., Kern, C., Columb, M. O., Smiley, R. M., & Blouin, J. (2008) · Pain · doi:10.1016/j.pain.2008.02.023 · Cited by 147 · see citing works

The genetics of the opioid system and specific drug addictions

Levran, O., Yuferov, V. P., & Kreek, M. J. (2012) · Human Genetics · doi:10.1007/s00439-012-1172-4 · Cited by 143 · see citing works

Analgesic Requirements After Major Abdominal Surgery are Associated with OPRM1 Gene Polymorphism Genotype and Haplotype

Hayashida, M., Nagashima, M., Satoh, Y., Katoh, R., Tagami, M., Ide, S., Kasai, S., Nishizawa, D., Ogai, Y., Hasegawa, J., et al. (2008) · Pharmacogenomics · doi:10.2217/14622416.9.11.1605 · Cited by 140 · see citing works

OPRM1 SNP (A118G): Involvement in disease development, treatment response, and animal models

Mague, S. D., & Blendy, J. A. (2010) · Drug and Alcohol Dependence · doi:10.1016/j.drugalcdep.2009.12.016 · Cited by 136 · see citing works

Association between OPRM1 gene polymorphisms and fentanyl sensitivity in patients undergoing painful cosmetic surgery

Fukuda, K., Hayashida, M., Ide, S., Saita, N., Kokita, Y., Kasai, S., Nishizawa, D., Ogai, Y., Hasegawa, J., Nagashima, M., et al. (2009) · Pain · doi:10.1016/j.pain.2009.09.004 · Cited by 135 · see citing works

Ethnicity and OPRM Variant Independently Predict Pain Perception and Patient-Controlled Analgesia Usage for Post-Operative Pain

Tan, E.-C., Lim, E. C., Teo, Y.-Y., Lim, Y., Law, H.-Y., & Sia, A. T. (2009) · Molecular Pain · doi:10.1186/1744-8069-5-32 · Cited by 133 · see citing works

Genetics of Opioid Dependence: A Review of the Genetic Contribution to Opioid Dependence

Mistry, C. J., Bawor, M., Desai, D., Marsh, D. C., & Samaan, Z. (2014) · Current Psychiatry Reviews · doi:10.2174/1573400510666140320000928 · Cited by 133 · see citing works

A review of opioid addiction genetics

Crist, R. C., Reiner, B. C., & Berrettini, W. H. (2018) · Current Opinion in Psychology · doi:10.1016/j.copsyc.2018.07.014 · Cited by 131 · see citing works

Prevention of chronic postoperative pain: Cellular, molecular, and clinical insights for mechanism-based treatment approaches

Deumens, R., Steyaert, A., Forget, P., Schubert, M., Lavand'homme, P. M., Hermans, E., & Kock, M. D. (2013) · Progress in Neurobiology · doi:10.1016/j.pneurobio.2013.01.002 · Cited by 123 · see citing works

Social hedonic capacity is associated with the A118G polymorphism of the mu-opioid receptor gene (<i>OPRM1</i>) in adult healthy volunteers and psychiatric patients

Troisi, A., Frazzetto, G., Carola, V., Di Lorenzo, G., Coviello, M., D'Amato, F. R., Moles, A., Siracusano, A., & Gross, C. (2011) · Social Neuroscience · doi:10.1080/17470919.2010.482786 · Cited by 118 · see citing works

Tissue-Specific Glycosylation at the Glycopeptide Level

Medzihradszky, K. F., Kaasik, K., & Chalkley, R. J. (2015) · Molecular & Cellular Proteomics · doi:10.1074/mcp.m115.050393 · Cited by 118 · see citing works

μ opioid receptor, social behaviour and autism spectrum disorder: reward matters

Pellissier, L. P., Gandía, J., Laboute, T., Becker, J. A. J., & Merrer, J. L. (2017) · British Journal of Pharmacology · doi:10.1111/bph.13808 · Cited by 111 · see citing works

A common single nucleotide polymorphism A118G of the μ opioid receptor alters its N-glycosylation and protein stability

Huang, P., Chen, C., Mague, S. D., Blendy, J. A., & Liu‐Chen, L. (2011) · Biochemical Journal · doi:10.1042/bj20111050 · Cited by 113 · see citing works

Pharmacogenetics of OPRM1

Crist, R. C., & Berrettini, W. H. (2013) · Pharmacology Biochemistry and Behavior · doi:10.1016/j.pbb.2013.10.018 · Cited by 112 · see citing works

Search for genetic markers and functional variants involved in the development of opiate and cocaine addiction and treatment

Yuferov, V. P., Levran, O., Proudnikov, D., Nielsen, D. A., & Kreek, M. J. (2010) · Annals of the New York Academy of Sciences · doi:10.1111/j.1749-6632.2009.05275.x · Cited by 104 · see citing works

Consequences of the 118A>G polymorphism in the OPRM1 gene: translation from bench to bedside?

Mura, E., Govoni, S. M., Racchi, M., Carossa, Ranzani, G. N., Allegri, M., & van Schaik, A. (2013) · Journal of Pain Research · doi:10.2147/jpr.s42040 · Cited by 105 · see citing works

Single‐nucleotide polymorphism (A118G) in exon 1 ofOPRM1gene causes alteration in downstream signaling by mu‐opioid receptor and may contribute to the genetic risk for addiction

Deb, I., Chakraborty, J., Gangopadhyay, P. K., Choudhury, S. R., & Das, S. (2009) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.2009.06472.x · Cited by 104 · see citing works

Neuropathic and chronic pain stimuli downregulate central μ -opioid and dopaminergic transmission

Niikura, K., Narita, M., Butelman, E. R., Kreek, M. J., & Suzuki, T. (2010) · Trends in Pharmacological Sciences · doi:10.1016/j.tips.2010.04.003 · Cited by 103 · see citing works

The opioid system in depression

Jelen, L. A., Stone, J. M., Young, A. H., & Mehta, M. A. (2022) · Neuroscience & Biobehavioral Reviews · doi:10.1016/j.neubiorev.2022.104800 · Cited by 102 · see citing works

Epigenetic Variation in the Mu-Opioid Receptor Gene in Infants with Neonatal Abstinence Syndrome

Wachman, E. M., Hayes, M. J., Lester, B. M., Terrin, N. C., Brown, M. S., Nielsen, D. A., & Davis, J. M. (2014) · The Journal of Pediatrics · doi:10.1016/j.jpeds.2014.05.040 · Cited by 100 · see citing works

Pain-related effects of trait anger expression: Neural substrates and the role of endogenous opioid mechanisms

Bruehl, S., Burns, J. W., Chung, O. Y., & Chont, M. (2009) · Neuroscience &amp; Biobehavioral Reviews · doi:10.1016/j.neubiorev.2008.12.003 · Cited by 88 · see citing works

Common single nucleotide variants underlying drug addiction: more than a decade of research

Bühler, K., Giné, E., Echeverry‐Alzate, V., Calleja‐Conde, J., de Fonseca, F. R., & López‐Moreno, J. A. (2015) · Addiction Biology · doi:10.1111/adb.12204 · Cited by 88 · see citing works

The evolution of vertebrate opioid receptors

Craig, W. S. (2009) · Frontiers in bioscience · doi:10.2741/3306 · Cited by 89 · see citing works

Addiction pharmacogenetics

Patriquin, M. A., Bauer, I. E., Soares, J. C., Graham, D. P., & Nielsen, D. A. (2015) · Psychiatric Genetics · doi:10.1097/ypg.0000000000000095 · Cited by 86 · see citing works

The Role of the Asn40Asp Polymorphism of the Mu Opioid Receptor Gene (OPRM1) on Alcoholism Etiology and Treatment: A Critical Review

Ray, L. A., Barr, C. S., Blendy, J. A., Oslin, D. W., Goldman, D. A., & Anton, R. F. (2011) · Alcoholism Clinical and Experimental Research · doi:10.1111/j.1530-0277.2011.01633.x · Cited by 80 · see citing works

Molecular Imaging of Opioid and Dopamine Systems: Insights Into the Pharmacogenetics of Opioid Use Disorders

Burns, J. A., Kroll, D. S., Feldman, D. E., Liu, C. K., Manza, P., Wiers, C. E., Volkow, N. D., & Wang, G. (2019) · Frontiers in Psychiatry · doi:10.3389/fpsyt.2019.00626 · Cited by 72 · see citing works

Cis-Expression Quantitative Trait Loci Mapping Reveals Replicable Associations with Heroin Addiction in OPRM1

Hancock, D. B., Levy, J. L., Gaddis, N., Glasheen, C., Saccone, N. L., Page, G. P., Hulse, G. K., Wildenauer, D., Kelty, E. A., Schwab, S. G., et al. (2015) · Biological Psychiatry · doi:10.1016/j.biopsych.2015.01.003 · Cited by 70 · see citing works

Association Between Human Pain‐Related Genotypes and Variability in Opioid Analgesia: An Updated Review

Nielsen, L. M., Olesen, A. E., Branford, R., Christrup, L. L., Sato, H., & Drewes, A. M. (2014) · Pain Practice · doi:10.1111/papr.12232 · Cited by 70 · see citing works

Mu-opioid receptor (OPRM1) variation, oxytocin levels and maternal attachment in free-ranging rhesus macaques Macaca mulatta

Higham, J. P., Barr, C. S., Hoffman, C. L., Mandalaywala, T. M., Parker, K. J., & Maestripieri, D. (2011) · Behavioral Neuroscience · doi:10.1037/a0022695 · Cited by 69 · see citing works

Current evidence for a modulation of low back pain by human genetic variants

Tegeder, I., & Lötsch, J. (2009) · Journal of Cellular and Molecular Medicine · doi:10.1111/j.1582-4934.2009.00703.x · Cited by 69 · see citing works

Pharmacogenetic Treatments for Drug Addiction: Alcohol and Opiates

Haile, C. N., Kosten, T. A., & Kosten, T. R. (2008) · The American Journal of Drug and Alcohol Abuse · doi:10.1080/00952990802122564 · Cited by 71 · see citing works

Low μ-Opioid Receptor Status in Alcohol Dependence Identified by Combined Positron Emission Tomography and Post-Mortem Brain Analysis

Hermann, D., Hirth, N., Reimold, M., Batra, A., Smolka, M. N., Hoffmann, S., Kiefer, F., Noori, H. R., Sommer, W. H., Reischl, G., et al. (2017) · Neuropsychopharmacology · doi:10.1038/npp.2016.145 · Cited by 64 · see citing works

Recent Developments in the Study of Opioid Receptors

Cox, B. M. (2012) · Molecular Pharmacology · doi:10.1124/mol.112.083279 · Cited by 64 · see citing works

Pharmacological Consequence of the A118G μ Opioid Receptor Polymorphism on Morphine- and Fentanyl-mediated Modulation of Ca2+Channels in Humanized Mouse Sensory Neurons

Mahmoud, S., Thorsell, A., Sommer, W. H., Heilig, M. A., Holgate, J. K., Bartlett, S. E., & Ruiz-Velasco, V. (2011) · Anesthesiology · doi:10.1097/aln.0b013e318231fc11 · Cited by 62 · see citing works

Mouse Model of the OPRM1 (A118G) Polymorphism: Differential Heroin Self-Administration Behavior Compared with Wild-Type Mice

Zhang, Y., Picetti, R., Butelman, E. R., Ho, A., Blendy, J. A., & Kreek, M. J. (2014) · Neuropsychopharmacology · doi:10.1038/npp.2014.286 · Cited by 61 · see citing works

Pharmacogenomics of the Human µ-Opioid Receptor

Kasai, S., & Ikeda, K. (2011) · Pharmacogenomics · doi:10.2217/pgs.11.68 · Cited by 61 · see citing works

Litter Gender Composition and Sex Affect Maternal Behavior and DNA Methylation Levels of the Oprm1 Gene in Rat Offspring

Hao, Y., Huang, W., Nielsen, D. A., & Kosten, T. A. (2011) · Frontiers in Psychiatry · doi:10.3389/fpsyt.2011.00021 · Cited by 59 · see citing works

Drug-induced and genetic alterations in stress-responsive systems: implications for specific addictive diseases

Zhou, Y., Proudnikov, D., Yuferov, V., & Kreek, M. J. (2010) · Brain Research · doi:10.1016/j.brainres.2009.11.015 · Cited by 58 · see citing works

A Pharmacogenetic Determinant of Mu-Opioid Receptor Antagonist Effects on Alcohol Reward and Consumption: Evidence from Humanized Mice

Bilbao, A., Robinson, J. E., Heilig, M. A., Malanga, C. J., Spanagel, R., Sommer, W. H., & Thorsell, A. (2014) · Biological Psychiatry · doi:10.1016/j.biopsych.2014.08.021 · Cited by 58 · see citing works

Influence of Mu-Opioid Receptor Variant on Morphine Use and Self-Rated Pain Following Abdominal Hysterectomy

Sia, A. T. H., Lim, Y., Lim, E. C. P., Ocampo, C. E., Lim, W.-Y., Cheong, P., & Tan, E. (2013) · Journal of Pain · doi:10.1016/j.jpain.2013.03.008 · Cited by 58 · see citing works

Pharmacogenomic considerations in opioid analgesia

Landau, R. (2012) · Pharmacogenomics and Personalized Medicine · doi:10.2147/pgpm.s23422 · Cited by 57 · see citing works

Common and specific liability to addiction: Approaches to association studies of opioid addiction

Nielsen, D. A., & Kreek, M. J. (2012) · Drug and Alcohol Dependence · doi:10.1016/j.drugalcdep.2012.03.026 · Cited by 55 · see citing works

The Role of Hydromorphone and OPRM1 in Postoperative Pain Relief with Hydrocodone

Jortani, S. A. (2013) · Pain Physician · doi:10.36076/ppj.2013/16/e227 · Cited by 55 · see citing works

Polymorphism of the μ-Opioid Receptor Gene (OPRM1 118A>G) Affects Fentanyl-Induced Analgesia During Anesthesia and Recovery

Wu, W. D., Wang, Y., Fang, Y., & Zhou, H. (2009) · Molecular Diagnosis & Therapy · doi:10.1007/bf03256337 · Cited by 55 · see citing works

Cortisol Stress Response in Men and Women Modulated Differentially by the Mu-Opioid Receptor Gene Polymorphism OPRM1 A118G

Lovallo, W. R., Enoch, M., Acheson, A., Cohoon, A. J., Sorocco, K. H., Hodgkinson, C. A., Vincent, A. S., Glahn, D. C., & Goldman, D. A. (2015) · Neuropsychopharmacology · doi:10.1038/npp.2015.101 · Cited by 54 · see citing works

A Heroin Addiction Severity-Associated Intronic Single Nucleotide Polymorphism Modulates Alternative Pre-mRNA Splicing of the Opioid Receptor Gene OPRM1 via hnRNPH Interactions

Xu, J., Lu, Z., Xu, M., Pan, L., Deng, Y., Xie, X., Liu, H., Ding, S., Hurd, Y. L., Pasternak, G. W., et al. (2014) · Journal of Neuroscience · doi:10.1523/jneurosci.3986-13.2014 · Cited by 55 · see citing works

Cannabinoid Receptor Type 1 and mu-Opioid Receptor Polymorphisms Are Associated With Cyclic Vomiting Syndrome

Wasilewski, A., Lewandowska, U., Mosińska, P., Watała, C. W., Storr, M., Fichna, J., & Venkatesan, T. (2017) · The American Journal of Gastroenterology · doi:10.1038/ajg.2017.73 · Cited by 55 · see citing works

Opiates, overeating and obesity: a psychogenetic analysis

Davis, C. A., Zai, C. C. H., Levitan, R. D., Kaplan, A. S., Carter, J. C., Reid‐Westoby, C., Curtis, C., Wight, K., & Kennedy, J. L. (2011) · International Journal of Obesity · doi:10.1038/ijo.2010.276 · Cited by 51 · see citing works

Child μ-Opioid Receptor Gene Variant Influences Parent–Child Relations

Copeland, W., Sun, H., Costello, E. J., Angold, A. C., Heilig, M. A., & Barr, C. S. (2011) · Neuropsychopharmacology · doi:10.1038/npp.2010.251 · Cited by 50 · see citing works

Endogenous opiates and behavior: 2007

Bodnar, R. J. (2008) · Peptides · doi:10.1016/j.peptides.2008.09.007 · Cited by 51 · see citing works

Association of OPRM1 A118G variant with risk of morphine-induced respiratory depression following spine fusion in adolescents

Chidambaran, V., Mavi, J., Esslinger, H. R., Pilipenko, V. V., Martin, L. J., Zhang, K., & Sadhasivam, S. (2014) · The Pharmacogenomics Journal · doi:10.1038/tpj.2014.59 · Cited by 47 · see citing works

Mechanisms of the placebo effect in pain and psychiatric disorders

Holmes, R. D., Tiwari, A. K., & Kennedy, J. (2016) · The Pharmacogenomics Journal · doi:10.1038/tpj.2016.15 · Cited by 46 · see citing works

Genetics of Opiate Addiction

Reed, B., Butelman, E. R., Yuferov, V. P., Randesi, M., & Kreek, M. J. (2014) · Current Psychiatry Reports · doi:10.1007/s11920-014-0504-6 · Cited by 46 · see citing works

Tobacco smoking produces greater striatal dopamine release in G-allele carriers with mu opioid receptor A118G polymorphism

Domino, E. F., Evans, C., Ni, L., Guthrie, S. K., Koeppe, R. A., & Zubieta, J. (2012) · Progress in Neuro-Psychopharmacology and Biological Psychiatry · doi:10.1016/j.pnpbp.2012.04.003 · Cited by 43 · see citing works

Immune Response Activation and Immunomodulation

Tyagi, R. K., & Bisen, P. S. (2019) · IntechOpen eBooks · doi:10.5772/intechopen.73708 · Cited by 44 · see citing works

Analgesia and central side‐effects: two separate dimensions of morphine response

Droney, J., Gretton, S. K., Sato, H., Ross, J. R., Branford, R., Welsh, K. I., Cookson, W., & Riley, J. L. (2012) · British Journal of Clinical Pharmacology · doi:10.1111/bcp.12008 · Cited by 40 · see citing works

Mouse strain differences in locomotor, sensitisation and rewarding effect of heroin; association with alterations in MOP‐r activation and dopamine transporter binding

Bailey, A., Metaxas, A., Al‐Hasani, R., Keyworth, H. L., Forster, D. M., & Kitchen, I. (2010) · European Journal of Neuroscience · doi:10.1111/j.1460-9568.2010.07104.x · Cited by 40 · see citing works

Addiction associated N40D mu-opioid receptor variant modulates synaptic function in human neurons

Halikere, A., Popova, D., Scarnati, M. S., Hamod, A., Swerdel, M. R., Moore, J. C., Tischfield, J. A., Hart, R. P., & Pang, Z. P. (2019) · Molecular Psychiatry · doi:10.1038/s41380-019-0507-0 · Cited by 37 · see citing works

Systematic review and meta‐analysis of the moderating effect of rs1799971 in OPRM1, the mu‐opioid receptor gene, on response to naltrexone treatment of alcohol use disorder

Hartwell, E. E., Feinn, R., Morris, P. E., Gelernter, J. E., Krystal, J. H., Arias, A. J., Hoffman, M., Petrakis, I. L., Gueorguieva, R. V., Schacht, J. P., et al. (2020) · Addiction · doi:10.1111/add.14975 · Cited by 39 · see citing works

Low frequency genetic variants in the μ-opioid receptor (OPRM1) affect risk for addiction to heroin and cocaine

Clarke, T., Crist, R. C., Kampman, K. M., Dackis, C. A., Pettinati, H. M., O’Brien, C. P., Oslin, D. W., Ferraro, T. N., Lohoff, F. W., & Berrettini, W. H. (2013) · Neuroscience Letters · doi:10.1016/j.neulet.2013.02.018 · Cited by 39 · see citing works

OPRM1 gene variation influences hypothalamic–pituitary–adrenal axis function in response to a variety of stressors in rhesus macaques

Schwandt, M. L., Lindell, S. G., Higley, J. D., Suomi, S. J., Heilig, M. A., & Barr, C. S. (2011) · Psychoneuroendocrinology · doi:10.1016/j.psyneuen.2011.03.002 · Cited by 37 · see citing works

Functionalmuopioid receptor polymorphism (OPRM1 A118G) associated with heroin use outcomes in Caucasian males: A pilot study

Woodcock, E. A., Lundahl, L. H., Burmeister, M., & Greenwald, M. K. (2015) · American Journal on Addictions · doi:10.1111/ajad.12187 · Cited by 38 · see citing works

Mu‐opioid receptor A118G polymorphism in healthy volunteers affects hypothalamic–pituitary–adrenal axis adrenocorticotropic hormone stress response to metyrapone

Ducat, E. A., Ray, B. M., Bart, G. B., Umemura, Y., Varon, J., Ho, A., & Kreek, M. J. (2011) · Addiction Biology · doi:10.1111/j.1369-1600.2011.00313.x · Cited by 37 · see citing works

µ-Opioid Receptor Gene Variant OPRM1 118 A>G: A Summary of its Molecular and Clinical Consequences for Pain

Walter, C., Doehring, A., Oertel, B. G., & Lötsch, J. (2013) · Pharmacogenomics · doi:10.2217/pgs.13.187 · Cited by 36 · see citing works

Genetic Variation of the Mu Opioid Receptor (OPRM1) and Dopamine D2 Receptor (DRD2) is Related to Smoking Differences in Patients with Schizophrenia but not Bipolar Disorder

Hirasawa-Fujita, M., Bly, M. J., Ellingrod, V. L., Dalack, G. W., & Domino, E. F. (2017) · Clinical Schizophrenia & Related Psychoses · doi:10.3371/1935-1232-11.1.39 · Cited by 35 · see citing works

Variable response to opioid treatment: any genetic predictors within sight?

Skorpen, F., Laugsand, E., Klepstad, P., & Kaasa, S. (2008) · Palliative Medicine · doi:10.1177/0269216308089302 · Cited by 35 · see citing works

Alcohol: A stimulant activating brain stress responsive systems with persistent neuroadaptation

Zhou, Y., & Kreek, M. J. (2014) · Neuropharmacology · doi:10.1016/j.neuropharm.2014.05.044 · Cited by 33 · see citing works

A118G Polymorphism of OPRM1 Gene is Associated with Schizophrenia

Šerý, O., Přikryl, R., Častulík, L., & Šťastný, F. (2010) · Journal of Molecular Neuroscience · doi:10.1007/s12031-010-9327-z · Cited by 33 · see citing works

Pharmacogenomics for personalized pain medicine

Ko, T., Wong, C., Wu, J.-Y., & Chen, Y.-T. (2016) · Acta anaesthesiologica Taiwanica · doi:10.1016/j.aat.2016.02.001 · Cited by 32 · see citing works

Are Opioids Effective in Relieving Neuropathic Pain?

Schembri, E. (2018) · SN Comprehensive Clinical Medicine · doi:10.1007/s42399-018-0009-4 · Cited by 32 · see citing works

Pharmacogenetics of Addiction Therapy

Nielsen, D. A., Nielsen, E. M., Dasari, T., & Spellicy, C. J. (2014) · Methods in molecular biology · doi:10.1007/978-1-4939-0956-8_15 · Cited by 31 · see citing works

Placebo effects and the molecular biological components involved

Cai, L., & He, L. (2019) · General Psychiatry · doi:10.1136/gpsych-2019-100089 · Cited by 32 · see citing works

Carbamidomethylation Side Reactions May Lead to Glycan Misassignments in Glycopeptide Analysis

Darula, Z., & Medzihradszky, K. F. (2015) · Analytical Chemistry · doi:10.1021/acs.analchem.5b01121 · Cited by 31 · see citing works

Buprenorphine signalling is compromised at the N 40 D polymorphism of the human μ opioid receptor in vitro

Knapman, A., Santiago, M., & Connor, M. A. (2014) · British Journal of Pharmacology · doi:10.1111/bph.12785 · Cited by 29 · see citing works

A machine-learned knowledge discovery method for associating complex phenotypes with complex genotypes. Application to pain

Lötsch, J., & Ultsch, A. (2013) · Journal of Biomedical Informatics · doi:10.1016/j.jbi.2013.07.010 · Cited by 29 · see citing works

Nicotine-specific and non-specific effects of cigarette smoking on endogenous opioid mechanisms

Nuechterlein, E. B., Ni, L., Domino, E. F., & Zubieta, J. (2016) · Progress in Neuro-Psychopharmacology and Biological Psychiatry · doi:10.1016/j.pnpbp.2016.04.006 · Cited by 28 · see citing works

Bidirectional translational research: Progress in understanding addictive diseases

Kreek, M. J., Schlussman, S. D., Reed, B., Zhang, Y., Nielsen, D. A., Levran, O., Zhou, Y., & Butelman, E. R. (2008) · Neuropharmacology · doi:10.1016/j.neuropharm.2008.07.042 · Cited by 28 · see citing works

Receptor Reserve Moderates Mesolimbic Responses to Opioids in a Humanized Mouse Model of the OPRM1 A118G Polymorphism

Robinson, J. E., Vardy, E., DiBerto, J. F., Chefer, V. I., White, K. L., Fish, E. W., Chen, M., Gigante, E. D., Krouse, M. C., Sun, H., et al. (2015) · Neuropsychopharmacology · doi:10.1038/npp.2015.109 · Cited by 28 · see citing works

Functional Polymorphism of the Mu-Opioid Receptor Gene (OPRM1) Influences Reinforcement Learning in Humans

Lee, M. R., Gallen, C. L., Zhang, X., Hodgkinson, C. A., Goldman, D., Stein, E. A., & Barr, C. S. (2011) · PLoS ONE · doi:10.1371/journal.pone.0024203 · Cited by 27 · see citing works

Association study of OPRM1 polymorphisms with Schizophrenia in Han Chinese population

Ding, S., Chen, B., Zheng, Y., Lu, Q., Liu, L., & Zhuge, Q. C. (2013) · BMC Psychiatry · doi:10.1186/1471-244x-13-107 · Cited by 27 · see citing works

Pharmacogenetics of Methadone Response

Fonseca, F., & Torrens, M. (2017) · Molecular Diagnosis & Therapy · doi:10.1007/s40291-017-0311-y · Cited by 26 · see citing works

Micro Opioid Receptor A118G Polymorphism and Post-Operative Pain: Opioids' Effects on Heterozigous Patients

Capraris, A. D., Cinnella, G., Marolla, A., Salatto, P., Lima, S. D., Vetuschi, P., Consoletti, L., Gesualdo, L., & DAMBROSIO, M. (2011) · International Journal of Immunopathology and Pharmacology · doi:10.1177/039463201102400417 · Cited by 26 · see citing works

Effect of the A118G polymorphism on binding affinity, potency and agonist‐mediated endocytosis, desensitization, and resensitization of the human mu‐opioid receptor

Beyer, A., Koch, T., Schröder, H., Schulz, S., & Höllt, V. (2004) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.2004.02340.x · Cited by 258 · see citing works

The Mu-Opioid Receptor Gene Polymorphism (A118G) Alters HPA Axis Activation Induced by Opioid Receptor Blockade

Wand, G. S. (2002) · Neuropsychopharmacology · doi:10.1016/s0893-133x(01)00294-9 · Cited by 246 · see citing works

Stress Responsivity, Addiction, and a Functional Variant of the Human Mu-Opioid Receptor Gene

Kreek, M. J., & LaForge, K. S. (2007) · Molecular Interventions · doi:10.1124/mi.7.2.7 · Cited by 50 · see citing works

Functional differences in the mu opioid receptor SNP 118A >G are dependent on receptor splice‐variant and agonist‐specific recruitment of β‐arrestin

Patrick, C., Ettah, U., Nguyen, V., Hart, C., Atchley, E., Mallela, K. M. G., Scheinman, R. I., & Monte, A. A. (2024) · Clinical and Translational Science · doi:10.1111/cts.13888 · Cited by 3 · see citing works

Single-nucleotide polymorphism in the human mu opioid receptor gene alters β-endorphin binding and activity: Possible implications for opiate addiction

Bond, C. E., LaForge, K. S., Tian, M., Melia, D., Zhang, S., Borg, L., Gong, J., Schluger, J. H., Strong, J. A., Leal, S. M., et al. (1998) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.95.16.9608 · Cited by 1,072 · see citing works